Processa Pharmaceuticals, Inc. (PCSA) — Institutional Holders, Q2 2026
12 institutional investment managers reported a PCSA position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $498.3K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
PCSA in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- CITADEL ADVISORSNew · +21,306 sh+$40.9K
- Connective Capital ManagementAdded · +14,538 sh+$27.9K
- XTX Topco LtdNew · +13,292 sh+$25.5K
- JANE STREET GROUPNew · +13,264 sh+$25.5K
- StoneX GroupNew · +11,437 sh+$22.0K
Biggest sellers
- GEODE CAPITAL MANAGEMENTTrimmed · -2,818 sh-$5.4K
- CITIGROUPSold out · -14 sh-$27.00
- WELLS FARGO & COMPANYSold out · -6 sh-$12.00
PCSA 13F holders ranked 1–12 of 12
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Connective Capital Management#1 · 85,274 sh | 85,274 | $163.7K | 0.12% | +20.6% |
| 2 | Stonepine Capital Management#2 · 55,000 sh | 55,000 | $105.6K | 0.05% | 0.0% |
| 3 | GEODE CAPITAL MANAGEMENT#3 · 22,090 sh | 22,090 | $42.4K | 0.00% | -11.3% |
| 4 | CITADEL ADVISORS#4 · 21,306 sh | 21,306 | $40.9K | 0.00% | New |
| 5 | StoneX Group#5 · 11,437 sh | 11,437 | $29.6K | <0.01% | New |
| 6 | XTX Topco Ltd#6 · 13,292 sh | 13,292 | $25.5K | <0.01% | New |
| 7 | JANE STREET GROUP#7 · 13,264 sh | 13,264 | $25.5K | 0.00% | New |
| 8 | VANGUARD CAPITAL MANAGEMENT#8 · 12,729 sh | 12,729 | $24.4K | 0.00% | 0.0% |
| 9 | VANGUARD FIDUCIARY#9 · 10,857 sh | 10,857 | $20.8K | 0.00% | 0.0% |
| 10 | UBS Group AG#10 · 7,794 sh | 7,794 | $15.0K | 0.00% | +207.9% |
| 11 | Tower Research Capital (TRC)#11 · 2,499 sh | 2,499 | $4.8K | <0.01% | +172.2% |
| 12 | JONES FINANCIAL COMPANIES LLLP#12 · 7 sh | 7 | $13.00 | 0.00% | 0.0% |
Funds that sold out of PCSA in Q2 2026 (2)
Held PCSA at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| CITIGROUP14 sh | 14 | $35.00 |
| WELLS FARGO & COMPANY6 sh | 6 | $15.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.